The dark side of semaglutide, while relatively rare, underscores the importance of a thorough and personalized medical assessment prior to and during treatment with Wegovy
To assess the associations of semaglutide with incident CUD (first time diagnosis of CUD), the study population included 83,189 patients who had active medical encounters for the diagnosis of obesity in 6/202112/2022, were for the first time (new users design) prescribed semaglutide or non-GLP-1RA anti-obesity medications (bupropion, naltrexone, orlistat, topiramate, phentermine) [39] during 6/2021-12/2022 (time zero or index event), had no diagnosis of CUD on or before the index event and had a diagnosis of at least one of obesity-associated comorbidities (T2D, hypertension, hypercholesterolemia, hyperlipidemia, heart diseases, stroke) on or before the index event
For semaglutide users specifically, the methylcobalamin advantage is about bypassing a compromised absorption system
Managing side effects starts with starting low and going slowexactly how PlexusDx structures its dosing protocol
Any time the vial that arrives looks different from what you expected, verify with your provider before injecting